Close

Bristol-Myers Squibb (BMY) Announces FDA Acceptance of Three Daklinza SNDAs

October 6, 2015 7:01 AM EDT Send to a Friend
Bristol-Myers Squibb (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and review three ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login